LONDON, Jan 31 (Reuters) - AstraZeneca Plc (AZN.L: Quote, Profile , Research) has signed a lung drug deal with Argenta Discovery which could earn the unlisted British biotech company up to $500 million, the two companies said on Wednesday.
LONDON, Jan 31 (Reuters) - AstraZeneca Plc (AZN.L: Quote, Profile , Research) has signed a lung drug deal with Argenta Discovery which could earn the unlisted British biotech company up to $500 million, the two companies said on Wednesday.
